SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paraskevi V Voulgari, Alexandros A Drosos, Adalimumab in the treatment of rheumatoid arthritis, Expert Opinion on Biological Therapy, 2014, 14, 4, 549

    CrossRef

  2. 2
    Laura Hunt, Paul Emery, Defining populations at risk of rheumatoid arthritis: the first steps to prevention, Nature Reviews Rheumatology, 2014, 10, 9, 521

    CrossRef

  3. 3
    Jeffrey A. Sparks, Karen H. Costenbader, Genetics, Environment, and Gene-Environment Interactions in the Development of Systemic Rheumatic Diseases, Rheumatic Disease Clinics of North America, 2014,

    CrossRef

  4. 4
    Kevin D. Deane, Hani El-Gabalawy, Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE, Nature Reviews Rheumatology, 2014, 10, 4, 212

    CrossRef

  5. 5
    Samina A. Turk, Marian H. van Beers-Tas, Dirkjan van Schaardenburg, Prediction of Future Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2014,

    CrossRef

  6. 6
    Axel Finckh, Kevin D. Deane, Prevention of Rheumatic Diseases, Rheumatic Disease Clinics of North America, 2014,

    CrossRef

  7. 7
    Björn Svensson, Ingiäld Hafström, Malin C Erlandsson, Kristina Forslind, Maria I Bokarewa, Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study, Arthritis Research & Therapy, 2014, 16, 1, R12

    CrossRef

  8. 8
    E. W. Karlson, D. van Schaaardenburg, A. H. van der Helm-van Mil, Strategies to predict rheumatoid arthritis development in at-risk populations, Rheumatology, 2014,

    CrossRef

  9. 9
    Kevin D. Deane, Can rheumatoid arthritis be prevented?, Best Practice & Research Clinical Rheumatology, 2013, 27, 4, 467

    CrossRef